Dr. Ju Li to join Chemizon as the Director of Analytical Chemistry.LONGMONT, Colo. -- Chemizon (KOSDAQ KOSDAQ Korean Securities Dealers Automated Quotations : 010170) announced today the hiring of Dr. Ju Li as Director of Analytical Chemistry. Dr. Li joins Chemizon after a number of years in the U.S. life sciences industry including stints at PPD (1) (Parallel Presence Detect) The method used by earlier SIMM memory modules to communicate their capacity to the computer. A binary number coming from a parallel set of pins was read by the system, with each pin representing one bit. Contrast with SPD. , Array Biopharma and most recently at Eisai Pharmaceuticals. At Eisai, Dr. Li led the analytical team that filed the NDA (Non Disclosure Agreement) An agreement signed between two parties that have to disclose confidential information to each other in order to do business. In general, the NDA states why the information is being divulged and stipulates that it cannot be used for any for Eisai's oncology drug EI 7389. "The addition of Dr. Ju Li significantly strengthens our management team," said Dr. Tony Piscopio, Chairman and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. of Chemizon. "Dr. Li's experience in both drug discovery and development will be a key asset to our global life science partners as we continue to build our fully integrated drug discovery platform." Dr. Li will be responsible for the global management of Chemizon's analytical chemistry teams and will work closely with the enzymology en·zy·mol·o·gy n. The branch of science that deals with the biochemical nature and activity of enzymes. enzymology the study of enzymes and enzymatic action. group, in managing and providing support to Chemizon's ADME team. About Chemizon Inc. Chemizon, a division of Optomagic Ltd., is a global provider of drug discovery and development capabilities to the pharmaceutical industry. Anchored by an experienced management team, Chemizon combines its vertically integrated discovery platform with a flexible business model to help collaborators develop best-in-class clinical candidates. Our expertise spans a broad range of therapeutic areas and target classes. In addition to providing an integrated discovery solution, we assist our collaborators with stand alone services including: custom synthesis, library design and synthesis, lead optimization, radiolabeling radiolabeling incorporation of a radioactive element into a compound in order to investigate its metabolism, fate and utilization. , ADME profiling, analytical method development and process chemistry. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion